Advisors Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Advisors Asset Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-7,486	Closed	-$387K	–	1526
2022 Q3	$387K	Sell	7,486 -266	-3%	-$11K	0.01%	991
2022 Q2	$192K	Sell	7,752 -133	-2%	-$2.93K	﹤0.01%	1168
2022 Q1	$198K	Sell	7,885 -727	-8%	-$20.4K	﹤0.01%	1234
2021 Q4	$314K	Sell	8,612 -273	-3%	-$9.58K	﹤0.01%	1122
2021 Q3	$152K	Buy	8,885 +1,203	+16%	+$18.7K	﹤0.01%	1250
2021 Q2	$103K	Buy	7,682 +1,612	+27%	+$39.7K	﹤0.01%	1300
2021 Q1	$311K	Buy	6,070 +2,051	+51%	+$123K	﹤0.01%	1129
2020 Q4	$249K	Buy	+4,019	New	+$230K	﹤0.01%	1155

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Advisors Asset Management's CCXI Position: Q4 2022 in Review

Advisors Asset Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 7,486 shares — an estimated $387K sold.

Advisors Asset Management first reported a position in CCXI in Q4 2020 and held it in 8 quarters. The position peaked at $387K in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Advisors Asset Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Advisors Asset Management sold 7,486 ChemoCentryx, Inc. shares in Q4 2022, an estimated $387K.
Advisors Asset Management first reported a position in ChemoCentryx, Inc. in Q4 2020 and held it in 8 quarters.
Advisors Asset Management's ChemoCentryx, Inc. position peaked at $387K in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Advisors Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.